Pasithea Therapeutics Corp
|Market Cap (Intraday)||19.15M|
|2yr Forward PE||N/A|
Pasithea Therapeutics Corp Stock, NASDAQ:KTTA
Pasithea Therapeutics Corp. is a biotechnology company focuses on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Steinman Lawrence J in May, 2020 and is headquartered in Miami Beach, FL.